The World's Greatest Investing Community
Results 41 - 50 of 117 : Previous 1 2 3 4 5 6 7 8 9 Next
Outsource it, baby.
Will ICON's Next Quarter Be a Bomb?
Look here for a clue.
Will Pharmaceutical Product Development Disappoint Analysts Next Quarter?
Look here for a clue.
Is this the best way to go after multiple indications?
Big Acquisition, Double-Digit Decline.
Charles River Labs buys into China big time.
How Do You Say 'Drug Development' in Mandarin?
Pharma heads east.
Pharma Researchers Need a Cure
As the industry changes, Pharmaceutical Product Development and Parexel International struggle.
Taking the Drug Industry's Temperature
Covance and Icon hint at broader pharmaceutical R&D trends.
5-Star Stocks Poised to Pop: inVentiv Health
Our CAPS community gives this stock a sterling bill of health.
Cost-cutting and revenue growth make WuXi a looker for the year.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK